Family Health Centers of San Diego, INC
Family Health Centers of San Diego, INC was paid $69.44M by Medicaid between Jan 2018 and Dec 2024, across 231 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 87% of everything it billed.
SAN DIEGO, CA 92104
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,509 | $8.76M | |
| 2019 | 84,559 | $7.93M | |
| 2020 | 156,406 | $10.26M | |
| 2021 | 176,811 | $11.42M | |
| 2022 | 131,161 | $8.77M | |
| 2023 | 161,868 | $11.45M | |
| 2024incomplete | 113,860 | $10.85M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 87% | 340,032 | 257,489 | $60.63M |
| 00003 | Internal/system code - not a standard HCPCS code | 12% | 35,851 | 26,916 | $8.44M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 8,336 | 6,872 | $47K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 48,194 | 44,555 | $33K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 1,365 | 1,186 | $32K |
| 0124A | <1% | 586 | 515 | $31K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 81,044 | 72,475 | $28K |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 217 | 172 | $23K |
| 0134A | <1% | 368 | 367 | $21K | |
| 0004A | <1% | 368 | 351 | $20K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 2,308 | 2,297 | $19K |
| 0013A | <1% | 287 | 277 | $17K |
219 more codes
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 194 | $12K |
| 0002A | <1% | 180 | $11K | |
| 0001A | <1% | 165 | $9K | |
| 0071A | <1% | 179 | $7K | |
| G9920 | Screening performed and negative | <1% | 1,517 | $6K |
| 0072A | <1% | 95 | $6K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,656 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 6,542 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,537 | $5K |
| 0154A | <1% | 89 | $4K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 313 | $4K |
| 98960 | <1% | 1,316 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 21,420 | $3K |
| 0111A | <1% | 67 | $2K | |
| 0003A | <1% | 38 | $2K | |
| 0073A | <1% | 37 | $2K | |
| 0012A | <1% | 25 | $1K | |
| 90480 | <1% | 252 | $1K | |
| 0011A | <1% | 33 | $1K | |
| 97803 | <1% | 7,709 | $873.69 | |
| 81025 | <1% | 7,311 | $872.39 | |
| 90686 | <1% | 6,916 | $863.00 | |
| 96156 | <1% | 34 | $752.33 | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 47 | $595.06 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 16,194 | $554.48 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 777 | $524.15 |
| 90756 | <1% | 3,040 | $460.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 125 | $457.60 |
| 97139 | <1% | 22 | $380.20 | |
| 87210 | <1% | 4,316 | $198.16 | |
| 80053 | Comprehensive metabolic panel | <1% | 8,902 | $189.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,991 | $102.90 |
| 80061 | Lipid panel | <1% | 8,233 | $92.32 |
| 86480 | <1% | 1,838 | $55.04 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,111 | $44.28 |
| 90746 | <1% | 208 | $43.55 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,157 | $40.52 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,407 | $40.50 |
| 86803 | <1% | 2,269 | $37.71 | |
| 86704 | <1% | 2,610 | $32.49 | |
| 86706 | <1% | 2,845 | $28.53 | |
| 87340 | <1% | 877 | $27.36 | |
| 96127 | <1% | 5,822 | $18.16 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,131 | $17.08 |
| 86592 | <1% | 5,225 | $7.68 | |
| 99000 | <1% | 7,394 | $7.26 | |
| 85018 | <1% | 4,487 | $6.19 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,979 | $4.50 |
| 99173 | <1% | 8,791 | $3.51 | |
| 81002 | <1% | 7,286 | $2.15 | |
| X4110 | 0% | 2,007 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 4,781 | $0.00 |
| 83540 | 0% | 898 | $0.00 | |
| 90710 | 0% | 964 | $0.00 | |
| Z6400 | 0% | 2,832 | $0.00 | |
| 85610 | 0% | 440 | $0.00 | |
| 90734 | 0% | 961 | $0.00 | |
| 90750 | 0% | 728 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 3,371 | $0.00 |
| 90670 | 0% | 3,432 | $0.00 | |
| 91312 | 0% | 424 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 830 | $0.00 |
| 84460 | 0% | 1,153 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 5,775 | $0.00 |
| 69209 | 0% | 380 | $0.00 | |
| 90648 | 0% | 805 | $0.00 | |
| 90715 | 0% | 2,372 | $0.00 | |
| 90700 | 0% | 1,037 | $0.00 | |
| 82570 | 0% | 741 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 4,936 | $0.00 |
| 96160 | 0% | 4,771 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 3,761 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 3,216 | $0.00 |
| 99401 | 0% | 744 | $0.00 | |
| 84439 | 0% | 420 | $0.00 | |
| 90461 | 0% | 4,321 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 7,514 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 2,222 | $0.00 |
| Z6304 | 0% | 908 | $0.00 | |
| 99404 | 0% | 945 | $0.00 | |
| A4267 | Contraceptive supply, condom, male, each | 0% | 476 | $0.00 |
| Z6300 | 0% | 568 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 152 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 2,514 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 614 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 307 | $0.00 |
| 2028F | 0% | 425 | $0.00 | |
| 84450 | 0% | 1,145 | $0.00 | |
| 90707 | 0% | 1,011 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 1,905 | $0.00 |
| 90633 | 0% | 2,378 | $0.00 | |
| 91313 | 0% | 295 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 174 | $0.00 |
| 81003 | 0% | 3,539 | $0.00 | |
| 82274 | 0% | 13 | $0.00 | |
| 82947 | 0% | 790 | $0.00 | |
| Z6208 | 0% | 103 | $0.00 | |
| Z6414 | 0% | 72 | $0.00 | |
| Z6200 | 0% | 335 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 1,102 | $0.00 |
| 99201 | 0% | 54 | $0.00 | |
| 80354 | 0% | 73 | $0.00 | |
| 90473 | 0% | 76 | $0.00 | |
| 97810 | 0% | 1,064 | $0.00 | |
| X3904 | 0% | 530 | $0.00 | |
| 92553 | 0% | 445 | $0.00 | |
| 99188 | 0% | 255 | $0.00 | |
| 90681 | 0% | 383 | $0.00 | |
| 99442 | 0% | 13 | $0.00 | |
| 91322 | 0% | 55 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 327 | $0.00 |
| Z6308 | 0% | 168 | $0.00 | |
| 91321 | 0% | 117 | $0.00 | |
| 90380 | 0% | 58 | $0.00 | |
| 85007 | 0% | 27 | $0.00 | |
| 82465 | 0% | 25 | $0.00 | |
| 90837 | Psychotherapy session, about an hour | 0% | 238 | $0.00 |
| 3078F | 0% | 154 | $0.00 | |
| 83718 | 0% | 25 | $0.00 | |
| 91300 | 0% | 34 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 60 | $0.00 |
| 90661 | 0% | 264 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 44 | $0.00 |
| 84550 | 0% | 42 | $0.00 | |
| 84702 | 0% | 12 | $0.00 | |
| 91311 | 0% | 22 | $0.00 | |
| 85014 | 0% | 25 | $0.00 | |
| 82247 | 0% | 47 | $0.00 | |
| 99382 | 0% | 16 | $0.00 | |
| 97811 | 0% | 15 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 13 | $0.00 |
| Z6500 | 0% | 31 | $0.00 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 0% | 12 | $0.00 |
| 86708 | 0% | 12 | $0.00 | |
| 82248 | 0% | 15 | $0.00 | |
| 11721 | 0% | 12 | $0.00 | |
| S5199 | Personal care item, nos, each | 0% | 13 | $0.00 |
| 87081 | 0% | 898 | $0.00 | |
| 90716 | 0% | 1,016 | $0.00 | |
| Z1034 | 0% | 9,779 | $0.00 | |
| 90619 | 0% | 791 | $0.00 | |
| 99459 | 0% | 548 | $0.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 0% | 724 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 757 | $0.00 |
| Z1032 | 0% | 498 | $0.00 | |
| 99385 | 0% | 287 | $0.00 | |
| 97802 | 0% | 2,393 | $0.00 | |
| 81015 | 0% | 3,652 | $0.00 | |
| 90698 | 0% | 1,845 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 3,738 | $0.00 |
| 90694 | 0% | 14 | $0.00 | |
| 82951 | 0% | 794 | $0.00 | |
| 90674 | 0% | 566 | $0.00 | |
| 82728 | 0% | 883 | $0.00 | |
| Z6406 | 0% | 680 | $0.00 | |
| 90696 | 0% | 810 | $0.00 | |
| 87428 | 0% | 2,506 | $0.00 | |
| 93000 | 0% | 1,662 | $0.00 | |
| 81001 | 0% | 578 | $0.00 | |
| 99381 | 0% | 998 | $0.00 | |
| 36416 | 0% | 558 | $0.00 | |
| 90680 | 0% | 2,148 | $0.00 | |
| 92551 | 0% | 9,999 | $0.00 | |
| 90651 | 0% | 2,810 | $0.00 | |
| 99384 | 0% | 41 | $0.00 | |
| 58100 | 0% | 13 | $0.00 | |
| 90688 | 0% | 280 | $0.00 | |
| 90656 | 0% | 548 | $0.00 | |
| 84153 | 0% | 94 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,763 | $0.00 |
| 87070 | 0% | 1,565 | $0.00 | |
| 83550 | 0% | 861 | $0.00 | |
| Z1038 | 0% | 263 | $0.00 | |
| Z6204 | 0% | 1,295 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 1,357 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 789 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 120 | $0.00 |
| 3074F | 0% | 156 | $0.00 | |
| Z6402 | 0% | 566 | $0.00 | |
| Z6410 | 0% | 1,035 | $0.00 | |
| 99406 | 0% | 689 | $0.00 | |
| 94760 | 0% | 1,359 | $0.00 | |
| 99383 | 0% | 44 | $0.00 | |
| 90697 | 0% | 1,341 | $0.00 | |
| X4304 | 0% | 759 | $0.00 | |
| 90677 | 0% | 992 | $0.00 | |
| 82043 | 0% | 675 | $0.00 | |
| 86140 | 0% | 397 | $0.00 | |
| 90732 | 0% | 152 | $0.00 | |
| 86769 | 0% | 77 | $0.00 | |
| 99402 | 0% | 296 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 153 | $0.00 |
| 85651 | 0% | 1,105 | $0.00 | |
| 80050 | General health panel | 0% | 281 | $0.00 |
| 90744 | 0% | 1,375 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 12 | $0.00 |
| 90739 | 0% | 193 | $0.00 | |
| 83690 | 0% | 59 | $0.00 | |
| 90381 | 0% | 53 | $0.00 | |
| 91307 | 0% | 47 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 183 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 52 | $0.00 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 104 | $0.00 |
| X3908 | 0% | 20 | $0.00 | |
| 99070 | 0% | 259 | $0.00 | |
| 91301 | 0% | 13 | $0.00 | |
| 3008F | 0% | 153 | $0.00 | |
| 85027 | 0% | 13 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 89 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 0% | 47 | $0.00 |
| 99441 | 0% | 33 | $0.00 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 66 | $0.00 |
| 86580 | 0% | 154 | $0.00 | |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 64 | $0.00 |
| J3490 | Unclassified drugs | 0% | 14 | $0.00 |
| 87536 | 0% | 15 | $0.00 | |
| 96161 | 0% | 77 | $0.00 | |
| 90474 | 0% | 16 | $0.00 | |
| X3924 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.